Specific data base for pharmacosurveillance

 

 

Continuous access is provided so that you can enter data for controlling

and monitoring adverse effects and non adverse effects (no suspected adverse effects).

 

User may perform case tracking and  generate PDF forms to send to the sponsor, perform audit trail for changes.